Buy MOTS-c peptide: what is actually in the vial
Buy MOTS-c peptide and the object that arrives is small and unglamorous: a sealed glass vial holding roughly a fingernail of white lyophilized powder, 10 mg of it, with a printed label and nothing else in the box. No diluent, no syringe, no leaflet, no dosing card. At the supplier we link that vial is $75.00, or $37.50 with the code PEPTIDEDECK, which works out at $3.75 per milligram.
The molecule is a 16-amino-acid peptide with the sequence MRWQEMGYIFYPRKLR, encoded not in the cell nucleus but in mitochondrial DNA, which is why it gets described as a mitochondrial-derived peptide. Freeze-dried, it is a raw substance rather than a preparation. A medicine is an active ingredient plus buffers, stabilizers, a fill volume, a sterility assurance level and a specification somebody is legally accountable for. This is the first item on that list and none of the rest.
That distinction is the whole of this page. We earn a commission if you buy through our link, set out on our affiliate disclosure page, and it is exactly why we would rather describe the purchase accurately than sell you a version of it that sounds more finished than it is.
What the evidence behind the molecule covers
MOTS-c was described by Lee and colleagues in Cell Metabolism in 2015 as a regulator of metabolic homeostasis acting through AMPK. That paper and most of what followed it are cell culture and rodent work. The published literature is searchable on PubMed, and it is worth ten minutes of anyone's time before a purchase, because the gap between what the research says and what a supplement marketer says about it is wide.
The nearest thing to a human program was CB4211, developed by CohBar. CB4211 is an analogue of MOTS-c rather than MOTS-c itself, which is a distinction that gets erased in marketing copy. It completed a Phase 1a/1b study, the company later wound down, and you can look up what was registered on ClinicalTrials.gov. There is no Phase 3 program, no large human efficacy trial, and no approval application in front of any regulator.
So the honest framing of the purchase is that you are buying a research compound at an early stage of investigation, not an unapproved version of something that works. Anyone telling you otherwise is describing a market rather than a literature.
What the label must carry, and what it must never claim
A legitimate research label is short and specific. It names the compound, the quantity in milligrams, the batch or lot number, storage conditions, the supplier, and a statement that the contents are for laboratory research use only and not for human consumption. The batch number is the load-bearing part, because it is what lets you match the vial in your hand against a published certificate of analysis.
What the label must not carry is a dose, a route of administration, a therapeutic claim or an instruction aimed at a person. A vial that arrives with a suggested protocol printed on it, or a seller who supplies one in the packing slip, has stepped across a line that exists for a reason, and it tells you something about how the rest of the operation is run.
Ascension publishes two third-party certificates per batch, Kovera Labs batch #24-05260628 and MZ Biolabs batch #24-01260229, as posted on the product listing. We have not run those samples ourselves and we would not claim to have. The check available to you is the one the batch number allows: read the certificate, then read the vial, and confirm the two describe the same material.
| MOTS-c research vial | A licensed prescription medicine | |
|---|---|---|
| Names the substance and quantity | Yes, 10 mg | Yes |
| Batch number printed | Yes | Yes |
| Dose or administration route | No, and must not | Yes |
| Patient information leaflet | No | Yes |
| Named responsible manufacturer | Supplier only | Marketing authorization holder |
| Adverse event reporting route | None | Yellow Card or FDA MedWatch |
| Recall mechanism | Vendor goodwill | Regulator-enforced |
The same molecule, two entirely different documents.
MOTS-c where to buy UK: no licensed route exists
MOTS-c where to buy UK is the second-biggest question on this topic, and the answer is that there is nothing licensed to buy. The MHRA has authorized no MOTS-c product, the European Medicines Agency has authorized none, and no marketing authorization application is pending in either territory. That is a different situation from a drug that is licensed elsewhere and merely unavailable locally.
Because there is no authorized product, no UK prescriber can write for it and no UK pharmacy can dispense it. A private clinic in London can prescribe plenty of things an NHS practice will not, but it cannot prescribe a substance that has no license anywhere, and unlicensed special-order routes exist for named-patient supply of manufactured medicines, not for research chemicals.
What UK buyers actually do is order from a US supplier, which turns a purchase into an import. That is where the risk changes shape, and it is the part most listings do not mention at all.
Customs, VAT and handling on a shipment into the UK or EU
A parcel of research material crossing into the UK or EU is subject to the same customs process as any other import, and to the medicines rules on top of it. Border officers can hold, query, return or seize a shipment they consider an unlicensed medicinal product. Nothing about a research-use label guarantees passage, and the outcome is not something the seller controls or indemnifies.
Even on a parcel that clears, the landed cost is not the vial price. Import VAT applies at the standard UK rate of 20% on the value of the goods plus shipping, low-value consignment relief no longer covers it, and the courier adds its own clearance or handling fee before it will release the parcel. Those charges arrive after the sale, usually as a text message demanding payment before delivery, and they are not refundable if you then decide against the purchase.
We will not help anyone around that process, and any seller offering to is telling you what kind of business it is. The risk sits with the buyer, in law and in practice: if a parcel is seized there is no product, no refund obligation beyond the vendor's own policy, and no complaint that goes anywhere. That is the honest position, and it is the reason the UK question deserves a page rather than a footnote. Our UK guide for retatrutide covers the same ground for the other research peptide readers ask about.
| Stage | What happens | Who carries the risk |
|---|---|---|
| Order placed with US supplier | Sold as research material, priced in dollars | Buyer |
| Border inspection | Parcel may be released, queried, returned or seized | Buyer |
| Import VAT | Standard UK rate of 20% on goods plus shipping | Buyer |
| Courier clearance fee | Charged before delivery, varies by carrier | Buyer |
| Parcel seized | No product, no regulatory remedy | Buyer |
| Product not as described | Vendor policy, then the card issuer | Buyer |
What a UK or EU order adds on top of the $37.50 vial price.
Why a UK stockist is usually a reshipper
Search for a domestic option and you will find sites with UK addresses, sterling pricing and next-day delivery language. Some hold real stock. Many are reshippers: they buy from the same handful of manufacturers, hold a small buffer, and pass a US or Chinese shipment through with a new label on it. The tell is usually documentation. A reshipper republishes a certificate of analysis with no batch number, or a batch number that never matches what arrives.
The second tell is the story about customs. A listing that promises guaranteed delivery, customs-free shipping or a reship on seizure is describing a business model built around parcels being lost, which is not a reassurance. Guaranteed clearance is not a service anyone can sell.
There is a simple test that costs nothing. Before ordering, ask the seller for the batch number of the vial they would actually ship and the certificate that covers it. A supplier holding real stock can answer in one line, because the number is printed on the carton in front of them. A reshipper cannot, because the stock does not exist yet and the certificate on the site belongs to somebody else's batch. Vagueness in that reply is the answer.
Buying domestically inside the UK does not fix the underlying position either. The material is still unlicensed, still unlabeled for human use, and still outside every protection that applies to medicines. It moves the customs risk off you and onto the seller. It changes nothing else.
What a clinic can legitimately offer a UK or EU patient
The reason this comparison belongs on the page is that most people searching to buy MOTS-c peptide are not chemists. They read about mitochondrial aging, they were quoted for a longevity package or an infusion course, and they are trying to work out whether ordering powder is the sensible version of that. So it is worth naming what the licensed side can actually do.
A UK or EU clinic can prescribe licensed medicines, including the GLP-1 medicines we cover across the site, run bloods, take a history, and be accountable to a regulator if it gets something wrong. It can also sell you a wellness package built on infusions and supplements, which is a legitimate service that is not MOTS-c and should not be described as MOTS-c. What no clinic in either territory can do is supply this compound, at any price, with any paperwork.
Set against that, the research route is cheap, fast and completely unsupervised. If a supervised option would meet the goal you actually have, our guide to the licensed weight and metabolic medicines is the more useful page. If you have read the literature and want the compound anyway, buy it understanding that the label, the certificate and your own care are the entire safety system.